跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 114 条关于
“Jupiter Bioventures”
全部
114
临床试验
11
药物
5
机构
9
资讯
89
去年
FDA Rejects Astellas' Izervay Update; Cytokinetics and Bayer Announce Aficamten Licensing Deal
9个月前
Jupiter Neurosciences Advances JOTROL into Phase 2a Parkinson's Trial Following FDA Clearance
去年
Jupiter Neurosciences Raises $11 Million in IPO to Advance Parkinson's Drug
11个月前
Asabys Partners Integrates Aliath Bioventures in €468M Strategic Consolidation to Build €1B Life Sciences Platform
10个月前
Jupiter Neurosciences Receives FDA IND Clearance for JOTROL Phase 2a Trial in Parkinson's Disease
7个月前
Jupiter Endovascular Completes SPIRARE II Trial Enrollment for Vertex Pulmonary Embolectomy System
去年
Jupiter Neurosciences Advances JOTROL Platform with Phase 2a Parkinson's Trial and Consumer Product Launch
去年
Jupiter Neurosciences Teams with Catalent to Manufacture JOTROL for Parkinson's Disease Trial
上个月
Jupiter Neurosciences Secures Exclusive U.S. Rights to PharmAla's ALA-002 in Deal Valued at Up to $100 Million
去年
Arrivo BioVentures Repurposes Depression Drug SP-624 Targeting Gender-Specific Gene Expression
第 1 页,共 9 页
上一页
下一页